Pneumonias associated with artificial respiration. Diagnosis and therapy;Beatmungsassoziierte pneumonien. Diagnostik und therapie

Anaesthesist

Volumn 52, Issue 3, 2003, Pages 265-292

  Krueger, W A ^a   Daschner, F D ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFOTIAM; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; FLUCLOXACILLIN; GENTAMICIN; IMIPENEM; LINCOSAMIDE; MEROPENEM; MEZLOCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; TAZOBACTAM; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC THERAPY; BRONCHOSCOPY; CLINICAL PROTOCOL; HUMAN; INCIDENCE; INTENSIVE CARE; PATHOGENESIS; PNEUMONIA; RADIODIAGNOSIS; REVIEW;

ALGORITHMS; ANTI-INFECTIVE AGENTS; BRONCHOSCOPY; HUMANS; PNEUMONIA; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; RESPIRATION, ARTIFICIAL; RISK FACTORS; VENTILATORS, MECHANICAL;

EID: 0037361193     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-003-0478-y     Document Type: Review

References (26)

1. Bonten MJ, Bergmans DCJJ, Stobberingh EE, Geest S van der, Leeuw PW de,Tiel FH van, Gaillard CA (1997) Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Respir Crit Care Med 156: 1820-1824
2. Bouza E, Brun-Buisson C, Chastre J, Ewig S, Fagon JY, Marquette CH, Niederman MS, Papazian L, Rello J, Rouby JJ, Saene H van, Welte T (2001) Ventilator-associated pneumonia. European Task Force on ventilator-associated pneumonia. Eur Respir J 17: 1034-1045
3. Campbell GD, Niederman MS, Broughton WA, Craven DE, Fein AM, Fink MP, Gleeson K, Hornick DB, Lynch JP, Mandell LA, Mason CM, Torres A, Wunderink RG (1996) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement. Am J Respir Crit Care Med 153: 1711-1725
4. Chastre J, Fagon JY, Bornet-Lecso M, Calvat S, Dombret MC, Al Khani R, Basset F, Gibert C (1995) Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 152: 231-240
5. Cook DJ,Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Bruin-Buisson C (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 129: 433-440
6. Eriksson U, Seifert B, Schaffner A (2001) Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial. BMJ 322: 1-6
7. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stéphan F, Similowski T, Mercat A, Diehl JL, Sollet JP, Tenaillon A (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 132: 621-630
8. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH (1997) Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 39: 677-686
9. González C, Rubio M, Romero-Vivas J, González G, Picazo JJ (1999) Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29: 1171-1177
10. Hayon J, Figlioline C, Combes A, Trouillet JL, Kassis N, Dombret MC, Gibert C, Chastre J (2002) Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am J Respir Crit Care Med 165: 41-46
11. Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K (2001) Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 29: 541-547
12. Johanson WG, Pierce AK, Sanford JP (1969) Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 281: 1137-1140
13. Kampf G, Wischnewski N, Schulgen G, Schumacher M, Daschner F (1998) Prevalence and risk factors for nosocomial lower respiratory tract infections in German hospitals. J Clin Epidemiol 51: 495-502
14. Kollef MH, Shapiro SD, Fraser VJ, Silver P, Murphy DM, Trovillion E, Hearns ML, Richards RD, Cracchilo L, Hossin L (1995) Mechanical ventilation with or without 7-day circuit changes. Ann Intern Med 123: 168-174
15. Krueger WA, Unertl K (1997) Verhalten bei Methicillin-resistentem Staphylococcus aureus (MRSA). In: Deutsche Akademie für Anästhesiologische Fortbildung (Hrsg) Refresher Course - aktuelles Wissen für den Anästhesisten, Bd 23. Springer, Berlin Heidelberg New York, pp 121-127
16. Krueger WA, Lenhart FP, Neeser G, Ruckdeschel G, Schreckhase H, Eissner HJ, Forst H, Eckart J, Peter K,Unertl KE (2002) Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients. A prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 166: 1029-1037
17. Lemmen SW, Engels I, Daschner FD (1997) Serum bactericidal activity of ceftazidime administered as continuous infusion of 3 g over 24 h versus intermittent bolus infusion of 2 g against Pseudomonas aeruginosa in healthy volunteers. J Antimicrob Chemother 39: 841-842
18. Montravers P, Fagon JY, Chastre J, Lesco M, Dombret MC, Trouillet JL, Gibert C (1993) Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 147: 38-44
19. Petri MG, König J, Moecke HP, Gramm HJ, Barkow H, Kujath P, Dennhart R, Schäfer H, Meyer N, Kalmar P, Thülig P, Müller J, Lode H (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med 23: 317-25
20. Rello J, Quintana E, Ausina V, Puzo C, Net A, Prats G (1990) Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis 142: 1320-1324
21. Rello J, Esandi ME, Díaz E, Mariscal D,Gallego M, Valles J (1998) The role of Candida sp, isolated from bronchoscopic samples in nonneutropenic patients. Chest 114:146-149
22. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Am J Respir Crit Care Med 162: 505-511
23. Torres A, Puig de la Bellacasa J, Xaubet A, Gonzalez J, Rodriguez-Roisin R, Jiménez de Anta MT, Agusti Vidal A (1989) Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis 140: 306-310
24. Vogel F, Naber KG, Wacha H, Shah P, Sörgel F, Kayser FH, Maschmeyer G, Lode H (1999) Parenterale Antibiotika bei Erwachsenen. Chemother J 8: 3-49
25. Waterer GW, Somes GW, Wunderink RG (2001) Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161: 1837-1842
26. Wunderink RG, Cammarata SK, Croos-Dabrera RV, Kollef MH (2002) Linezolid vs vancomycin: predictors of outcome in Methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Abstracts of the IDSA 40th Annual Meeting Chicago, October 24-27, 2002, 76 (Abstract 179)